You have seen a patient with cerebral venous sinus thrombosis following the administration of the new COVID-19 vaccine.
You have seen a patient with cerebral venous sinus thrombosis following the administration of the new COVID-19 vaccine. Your consultant wishes to share this information with the medical community as it is the first case presented in the country.
Which of the following study designs would be best used to share this information?
Take your subscriptions with you
Our mobile app allows you to access your interview and exam question banks wherever you are.